See stock splits, reverse splits, mergers and other announced capital actions with effective dates.
Choose today, tomorrow, the next 7 or 30 days. Every event keeps its announced local time and direct source link.
Revelation Biosciences' 1-for-7 common-stock reverse split becomes effective the morning of October 20. Fractional shares will be rounded up to the next whole share; common-stock par value remains unchanged.
Revelation Biosciences common stock begins 1-for-7 split-adjusted trading at Nasdaq's October 20 open under the unchanged REVB symbol. The new CUSIP will be 76135L887.
Moleculin's 1-for-20 reverse split takes effect October 20 at 12:01 AM US Eastern time. Cash is payable instead of fractional shares. Par value remains $0.001 per share and authorized common shares remain 500 million.
Moleculin shares begin trading on a 1-for-20 reverse-split-adjusted basis at the October 20 Nasdaq open. The symbol remains MBRX; the new CUSIP is 60855D507. Trading starts separately from the legal effective time of 12:01 AM US Eastern that day.
The MUSQ Global Music Industry Index ETF's last NYSE Arca trading day is expected on or about October 20, 2026. The issuer did not state it as a fixed date; new creation-unit orders close October 19, with liquidation and cash distribution expected on or about October 23.
The MUSQ Global Music Industry Index ETF is expected to liquidate on or about October 23, 2026 and distribute its remaining assets pro rata in cash after expenses. The issuer did not announce a final liquidation amount and described the date as approximate.
Azitra's 1-for-10 reverse split takes effect October 26 at 12:01 AM US Eastern time. No fractional shares will be issued; cash is payable instead. Adjusted trading begins separately at that day's market open.
Azitra shares begin trading on a 1-for-10 reverse-split-adjusted basis at the October 26 market open. The symbol remains AZTR; the new CUSIP is 05479L401. Par value per share is unchanged.
October 26 close of business is the record date for combining 25 existing shares into one. This is the reverse-split record date, not a merger-vote record date.
Holders of XBT Provider Digital Securities subject to compulsory redemption must submit a valid redemption notice and complete acceptable delivery by 26 October to elect physical delivery. Cash redemption is the default.
HCW Biologics shareholders will vote at the virtual special meeting on 27 October at 10:00 ET on warrants covering up to 618,682 shares from a private placement and an equity incentive plan containing a 2,500,000-share special reserve. The voting record date is 11 September.
The 1-for-25 reverse split takes effect October 28. Adjusted trading starts separately on October 29; fractional entitlements receive cash instead of fractional shares.
The authorized common-share limit increases from 75 million to 82 million on October 28. This is an authorization limit, not issued or outstanding shares.
OMEX starts reverse-split-adjusted trading at the October 29 market open following the 1-for-25 consolidation. The symbol remains OMEX; the new CUSIP is 676118300.
Brookfield will redeem all Series 51 shares on 1 November for C$22.44 per share plus accrued dividends and all Series 52 shares for C$22.00 per share. The final Series 52 dividend has a 15 October record date and 30 October payment date.
Each Series R preferred share automatically converts into five common shares. The special distribution ratio is one Series R share per common share; conversion changes share count and is not a cash payment.
Texas Capital expects its common-share ticker to change from TCBI to TXCP and its Series B preferred ticker from TCBI PRB to TXCP PRB on November 9. The issuer announced this as the scheduled effective date; shareholders do not need to take action.
CoinShares XBT Provider set 9 November as the compulsory redemption date for all outstanding Digital Securities under the programme. Holders who do not elect physical delivery will be redeemed in cash.
Kyivstar rescheduled its Capital Markets Day to 17 November. Management will discuss strategic priorities, business performance and outlook; attendance and webcast timing will be announced later.
Of the Verdera shares planned for distribution, 14,000,000 are subject to transfer restrictions. Restrictions on half of this group are due to be released on November 20, with the remainder due on February 20, 2027. The share distribution remains subject to required exchange filings and approvals.
Enpara Bank will hold its extraordinary general meeting in Istanbul on November 25 at 10:00. The agenda includes board elections and approval of the 2025 TSRS-compliant sustainability report and the 2026 sustainability auditor. November 24 is the final shareholder-eligibility date; no rights-exercise process is on the agenda.
Cash payments under the compulsory redemption are due on 9 November or as soon as practicable thereafter, and no later than 30 November.
The special meeting on proposed American Ocean Minerals merger proposals is scheduled for December 2 at 10:00 AM EST. This is not a merger-closing or ticker-change date.
Transfer restrictions on the remaining half of the 14,000,000 restricted Verdera shares planned for distribution are due to be released on February 20, 2027. The first half is scheduled for November 20, 2026. The share distribution remains subject to required exchange filings and approvals.
Investor Day, previously scheduled for November 13, 2026, has moved to March 31, 2027. The event will be exclusively in person at the Westlake, Texas headquarters, covering strategy and long-term growth opportunities.
Reliance Global's shareholder rights will expire at the close of business on 3 September 2027 unless they are redeemed, exchanged or terminated earlier under the plan.
Daily Journal's board-approved framework, adopted on 10 September 2026, permits the company to repurchase up to 35,000 common shares in the open market through 30 September 2027. The authorisation does not require any purchases and may be suspended or discontinued earlier.
October 13, 2027 is the announced validity end date for Aztek Teknoloji's share-repurchase program, which has a TRY 250 million funding cap. The program does not guarantee a specific purchase volume, and no exact end time was announced.
The non-transferable contingent value rights that Coherus Oncology will distribute on 7 October 2026 will expire on 7 October 2028.